Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
lgnd
/
Ligand Pharmaceuticals Inc
LGND
Add to Watchlist
297.150
USD
-3.380
-1.12%
Close 07-27 16:00(ET)
Quotes delayed by 15 min
297.500
USD
+297.500
After-hours (ET)
5.95B
Market Cap
38.72
P/E TTM
Ligand Pharmaceuticals Inc
297.150
-3.380
-1.12%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.37%
Vanguard Portfolio Management, LLC
5.49%
Janus Henderson Investors
4.97%
Vanguard Capital Management, LLC
4.23%
State Street Investment Management (US)
3.75%
Other
68.19%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.37%
Vanguard Portfolio Management, LLC
5.49%
Janus Henderson Investors
4.97%
Vanguard Capital Management, LLC
4.23%
State Street Investment Management (US)
3.75%
Other
68.19%
Shareholder Types
Shareholders
Proportion
Investment Advisor
58.25%
Investment Advisor/Hedge Fund
39.07%
Research Firm
3.67%
Individual Investor
2.39%
Pension Fund
1.67%
Bank and Trust
1.50%
Family Office
0.58%
Hedge Fund
0.52%
Venture Capital
0.08%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
634
20.97M
104.66%
-493.87K
2025Q4
592
20.48M
104.07%
-315.76K
2025Q3
541
20.07M
102.40%
-232.93K
2025Q2
535
19.71M
102.13%
-738.05K
2025Q1
554
19.82M
102.82%
-711.89K
2024Q4
546
19.28M
100.16%
-1.51M
2024Q3
543
19.17M
104.83%
-583.22K
2024Q2
527
18.31M
101.74%
-865.78K
2024Q1
520
17.60M
99.35%
-393.03K
2023Q4
527
16.97M
97.29%
-861.76K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
2.68M
13.44%
+52.70K
+2.01%
Dec 31, 2025
Janus Henderson Investors
995.40K
4.99%
-46.98K
-4.51%
Dec 31, 2025
State Street Investment Management (US)
751.21K
3.77%
+1.84K
+0.25%
Dec 31, 2025
Nomura Investment Management Business Trust
644.09K
3.23%
-107.69K
-14.33%
Dec 31, 2025
Fidelity Management & Research Company LLC
579.15K
2.9%
+121.92K
+26.67%
Dec 31, 2025
Chicago Capital, LLC
561.42K
2.82%
-7.19K
-1.26%
Dec 31, 2025
MFS Investment Management
507.02K
2.54%
-34.83K
-6.43%
Dec 31, 2025
Congress Asset Management Company, LLP
480.06K
2.41%
-187.25K
-28.06%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Franklin Genomic Advancements ETF
4.21%
Invesco Pharmaceuticals ETF
3.2%
State Street SPDR S&P Pharmaceuticals ETF
3.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.74%
Virtus LifeSci Biotech Products ETF
2.67%
Invesco S&P SmallCap Health Care ETF
2.3%
Pacer US Small Cap Cash Cows Growth Leaders ETF
1.73%
Invesco Dorsey Wright Healthcare Momentum ETF
1.64%
iShares U.S. Pharmaceuticals ETF
1.38%
First Trust Multi-Manager Small Cap Opportunities ETF
1.09%
View more
Franklin Genomic Advancements ETF
Proportion
4.21%
Invesco Pharmaceuticals ETF
Proportion
3.2%
State Street SPDR S&P Pharmaceuticals ETF
Proportion
3.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion
2.74%
Virtus LifeSci Biotech Products ETF
Proportion
2.67%
Invesco S&P SmallCap Health Care ETF
Proportion
2.3%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion
1.73%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion
1.64%
iShares U.S. Pharmaceuticals ETF
Proportion
1.38%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion
1.09%